291 related articles for article (PubMed ID: 30666436)
21. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis.
Slee A; Nazareth I; Bondaronek P; Liu Y; Cheng Z; Freemantle N
Lancet; 2019 Feb; 393(10173):768-777. PubMed ID: 30712879
[TBL] [Abstract][Full Text] [Related]
23. Differential effects of current specific treatments on behavioral and psychological symptoms in patients with Alzheimer's disease: a 12-month, randomized, open-label trial.
Cumbo E; Ligori LD
J Alzheimers Dis; 2014; 39(3):477-85. PubMed ID: 24164733
[TBL] [Abstract][Full Text] [Related]
24. Scales to assess efficacy and safety of pharmacologic agents in the treatment of behavioral and psychological symptoms of dementia.
De Deyn PP; Wirshing WC
J Clin Psychiatry; 2001; 62 Suppl 21():19-22. PubMed ID: 11584983
[TBL] [Abstract][Full Text] [Related]
25. [Efficacy and adverse reactions of antipsychotics for neuropsychiatric symptoms in dementia: a systematic review].
Zuidema SU; van Iersel MB; Koopmans RT; Verhey FR; Olde Rikkert MG
Ned Tijdschr Geneeskd; 2006 Jul; 150(28):1565-73. PubMed ID: 16886695
[TBL] [Abstract][Full Text] [Related]
26. A randomized, double-blind, crossover comparison of risperidone and haloperidol in Korean dementia patients with behavioral disturbances.
Suh GH; Son HG; Ju YS; Jcho KH; Yeon BK; Shin YM; Kee BS; Choi SK
Am J Geriatr Psychiatry; 2004; 12(5):509-16. PubMed ID: 15353389
[TBL] [Abstract][Full Text] [Related]
27. Variation in Placebo Effect Sizes in Clinical Trials of Oral Interventions for Management of the Behavioral and Psychological Symptoms of Dementia (BPSD): A Systematic Review and Meta-Analysis.
Hyde AJ; May BH; Xue CC; Zhang AL
Am J Geriatr Psychiatry; 2017 Sep; 25(9):994-1008. PubMed ID: 28363357
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence.
Sink KM; Holden KF; Yaffe K
JAMA; 2005 Feb; 293(5):596-608. PubMed ID: 15687315
[TBL] [Abstract][Full Text] [Related]
29. [Safety of atypical antipsychotics in the treatment of behavioral and psychological symptoms in dementia: a meta-analysis].
Xue XJ; He RL; Li WX; Xin JW; Ye QY; Chen XC; Pan XD
Zhonghua Yi Xue Za Zhi; 2018 Jul; 98(25):2030-2036. PubMed ID: 29996606
[No Abstract] [Full Text] [Related]
30. Acute Antipsychotic Treatment of Children and Adolescents With Schizophrenia-Spectrum Disorders: A Systematic Review and Network Meta-Analysis.
Pagsberg AK; Tarp S; Glintborg D; Stenstrøm AD; Fink-Jensen A; Correll CU; Christensen R
J Am Acad Child Adolesc Psychiatry; 2017 Mar; 56(3):191-202. PubMed ID: 28219485
[TBL] [Abstract][Full Text] [Related]
31. Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia.
Suh GH; Greenspan AJ; Choi SK
Int J Geriatr Psychiatry; 2006 Jul; 21(7):654-60. PubMed ID: 16821257
[TBL] [Abstract][Full Text] [Related]
32. Comparative Efficacy and Safety of Antipsychotic Drugs for Tic Disorders: A Systematic Review and Bayesian Network Meta-Analysis.
Yang C; Hao Z; Zhang LL; Zhu CR; Zhu P; Guo Q
Pharmacopsychiatry; 2019 Jan; 52(1):7-15. PubMed ID: 29506305
[TBL] [Abstract][Full Text] [Related]
33. Behavioral and psychological symptoms in patients with dementia as a target for pharmacotherapy with risperidone.
Rabinowitz J; Katz IR; De Deyn PP; Brodaty H; Greenspan A; Davidson M
J Clin Psychiatry; 2004 Oct; 65(10):1329-34. PubMed ID: 15491235
[TBL] [Abstract][Full Text] [Related]
34. Galantamine versus risperidone for agitation in people with dementia: a randomized, twelve-week, single-center study.
Freund-Levi Y; Bloniecki V; Auestad B; Tysen Bäckström AC; Lärksäter M; Aarsland D
Dement Geriatr Cogn Disord; 2014; 38(3-4):234-44. PubMed ID: 24969380
[TBL] [Abstract][Full Text] [Related]
35. Comparative safety and efficacy of pharmacological and non-pharmacological interventions for the behavioral and psychological symptoms of dementia: protocol for a systematic review and network meta-analysis.
Watt J; Goodarzi Z; Tricco AC; Veroniki AA; Straus SE
Syst Rev; 2017 Sep; 6(1):182. PubMed ID: 28882156
[TBL] [Abstract][Full Text] [Related]
36. Medicinal herbs for the treatment of anxiety: A systematic review and network meta-analysis.
Zhang W; Yan Y; Wu Y; Yang H; Zhu P; Yan F; Zhao R; Tian P; Wang T; Fan Q; Su Z
Pharmacol Res; 2022 May; 179():106204. PubMed ID: 35378276
[TBL] [Abstract][Full Text] [Related]
37. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
[TBL] [Abstract][Full Text] [Related]
38. [The use of antipsychotics in patients with dementia].
Forlenza OV; Cretaz E; Diniz BS
Braz J Psychiatry; 2008 Sep; 30(3):265-70. PubMed ID: 18833428
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological treatments for alleviating agitation in dementia: a systematic review and network meta-analysis.
Kongpakwattana K; Sawangjit R; Tawankanjanachot I; Bell JS; Hilmer SN; Chaiyakunapruk N
Br J Clin Pharmacol; 2018 Jul; 84(7):1445-1456. PubMed ID: 29637593
[TBL] [Abstract][Full Text] [Related]
40. An overview of systematic reviews of pharmacological and non-pharmacological interventions for the treatment of behavioral and psychological symptoms of dementia.
Dyer SM; Harrison SL; Laver K; Whitehead C; Crotty M
Int Psychogeriatr; 2018 Mar; 30(3):295-309. PubMed ID: 29143695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
